A3AR antagonism mitigates metabolic dysfunction-associated steatotic liver disease by exploiting monocyte-derived Kupffer cell necroptosis and inflamm
- Metab.-Clin. Exp. Dec 26 2024, S0026-0495(24)00342-1 | https://doi.org/10.1016/j.metabol.2024.156114